tiprankstipranks
BioNTech sees FY24 CapEx EUR 400M-EUR 500M
PremiumThe FlyBioNTech sees FY24 CapEx EUR 400M-EUR 500M
3d ago
BioNTech backs FY24 revenue view EUR 2.5B-EUR 3.1B
PremiumThe Fly
BioNTech backs FY24 revenue view EUR 2.5B-EUR 3.1B
3d ago
BioNTech Q1 EPS EUR (1.31) vs. EUR 2.05 last year
PremiumThe Fly
BioNTech Q1 EPS EUR (1.31) vs. EUR 2.05 last year
3d ago
BioNTech announces Phase 1 trial follow up data for mRNA-based iNeST candidate
PremiumThe FlyBioNTech announces Phase 1 trial follow up data for mRNA-based iNeST candidate
1M ago
Three-year Phase 1 Follow-Up Data  for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
PremiumPress Releases
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
1M ago
BioNTech price target lowered to $101 from $110 at UBS
PremiumThe Fly
BioNTech price target lowered to $101 from $110 at UBS
1M ago
Biontech’s Bold AI Leap: Navigating Risks and Competition in the Tech Integration Era
PremiumCompany AnnouncementsBiontech’s Bold AI Leap: Navigating Risks and Competition in the Tech Integration Era
2M ago
BioNTech Expects Continued Growth into 2024
PremiumCompany Announcements
BioNTech Expects Continued Growth into 2024
2M ago
Options Volatility and Implied Earnings Moves Today, March 20, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 20, 2024
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100